These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8854241)

  • 1. Evaluation in vivo of a potent parathyroid hormone antagonist: [Nle8,18,D-Trp12,Tyr34]bPTH(7-34)NH2.
    Dresner-Pollak R; Yang QM; Behar V; Nakamoto C; Chorev M; Rosenblatt M
    J Bone Miner Res; 1996 Aug; 11(8):1061-5. PubMed ID: 8854241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2.
    Goldman ME; McKee RL; Caulfield MP; Reagan JE; Levy JJ; Gay CT; DeHaven PA; Rosenblatt M; Chorev M
    Endocrinology; 1988 Nov; 123(5):2597-9. PubMed ID: 2844517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
    McKee RL; Goldman ME; Caulfield MP; DeHaven PA; Levy JJ; Nutt RF; Rosenblatt M
    Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by (D-Trp12,Tyr34)bPTH(7-34)amide of PTH and PTHrP effects on Pi transport in renal cells.
    Pizurki L; Rizzoli R; Bonjour JP
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F389-92. PubMed ID: 2167018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of bone-derived ROS 17/2.8 cells with dexamethasone and pertussis toxin enables detection of partial agonist activity for parathyroid hormone antagonists.
    McKee RL; Caulfield MP; Rosenblatt M
    Endocrinology; 1990 Jul; 127(1):76-82. PubMed ID: 2163326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and pharmacokinetics of a potent peptide antagonist of parathyroid hormone and parathyroid hormone-related protein in the rat.
    Schetz JA; Mayr CA; Taylor JE; Rosenblatt M; Chorev M; Davis TP
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1456-62. PubMed ID: 7562522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of cAMP accumulation and phosphate uptake in opossum kidney (OK) cells with parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrP).
    Muff R; Caulfield MP; Fischer JA
    Peptides; 1990; 11(5):945-9. PubMed ID: 2178252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH2 by substitution of PTH amino acids at positions 10 and 11.
    Nutt RF; Caulfield MP; Levy JJ; Gibbons SW; Rosenblatt M; McKee RL
    Endocrinology; 1990 Jul; 127(1):491-3. PubMed ID: 2163325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a parathyroid hormone antagonist in an in vivo multiparameter bioassay.
    Horiuchi N; Rosenblatt M
    Am J Physiol; 1987 Aug; 253(2 Pt 1):E187-92. PubMed ID: 3039857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiresponse parathyroid hormone assay: an inhibitor has agonist properties in vivo.
    Horiuchi N; Rosenblatt M; Keutmann HT; Potts JT; Holick MF
    Am J Physiol; 1983 Jun; 244(6):E589-95. PubMed ID: 6305202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of in vitro bone resorption by a parathyroid hormone receptor antagonist in the canine adenocarcinoma model of humoral hypercalcemia of malignancy.
    Rosol TJ; Capen CC
    Endocrinology; 1988 May; 122(5):2098-102. PubMed ID: 2834184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of hydrophobic substitutions at position 18 on the potency of parathyroid hormone antagonists.
    Chorev M; Roubini E; Goldman ME; McKee RL; Gibbons SW; Reagan JE; Caulfield MP; Rosenblatt M
    Int J Pept Protein Res; 1990 Nov; 36(5):465-70. PubMed ID: 2177456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation by plasma may be responsible for lack of efficacy of parathyroid hormone antagonists in hypercalcemia of malignancy.
    Kukreja SC; D'Anza JJ; Wimbiscus SA; Fisher JE; McKee RL; Caulfield MP; Rosenblatt M
    Endocrinology; 1994 May; 134(5):2184-8. PubMed ID: 8156920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of position 12 in parathyroid hormone and parathyroid hormone related protein: toward the design of highly potent antagonists.
    Chorev M; Goldman ME; McKee RL; Roubini E; Levy JJ; Gay CT; Reagan JE; Fisher JE; Caporale LH; Golub EE
    Biochemistry; 1990 Feb; 29(6):1580-6. PubMed ID: 2334716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The arterio-venous difference for immunoreactive parathyroid hormone and the production of adenosine 3,'5'-monophosphate by isolated perfused bone: studies with analogs of parathyroid hormone.
    Martin KJ; Bellorin-Font E; Freitag J; Rosenblatt M; Slatopolsky E
    Endocrinology; 1981 Sep; 109(3):956-9. PubMed ID: 6266817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of parathyroid hormone: relative sensitivity of rabbit renal microvessel and tubule adenylate cyclases to oxidized PTH and PTH inhibitors.
    Helwig JJ; Yang MC; Bollack C; Judes C; Pang PK
    Eur J Pharmacol; 1987 Aug; 140(3):247-57. PubMed ID: 2820761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 7-34 analog of the parathyroid hormone-related protein has potent antagonist and partial agonist activity in vivo.
    Horiuchi N; Hongo T; Clemens TL
    Bone Miner; 1991 Mar; 12(3):181-8. PubMed ID: 1850633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the in vivo parathyroid hormone-mediated calcemic response in rats by a synthetic hormone antagonist.
    Doppelt SH; Neer RM; Nussbaum SR; Federico P; Potts JT; Rosenblatt M
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7557-60. PubMed ID: 3463984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human PTH-(3-34) inhibited the effects of human parathyroid hormone-related protein on phosphate uptake in a cultured renal cell line (OK cells).
    Nakai M; Fukase M; Yamaguchi T; Tsukamoto T; Fujii N; Fujita T
    J Bone Miner Res; 1990 Oct; 5(10):995-1002. PubMed ID: 1964359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOST is a target gene for PTH in bone.
    Keller H; Kneissel M
    Bone; 2005 Aug; 37(2):148-58. PubMed ID: 15946907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.